Similar articles for PMID: 27629686

Year	Number of Results
1980	1
1981	1
1984	1
1991	1
1992	2
1993	2
1994	3
1995	7
1996	4
1997	11
1998	8
1999	2
2000	4
2001	5
2002	2
2003	5
2004	7
2005	1
2006	6
2007	1
2008	3
2011	2
2012	3
2013	2
2014	5
2015	6
2016	5
2017	1
2018	2
2019	1
2020	2
2021	1
2022	1
2023	3
2025	0

1

Treatment of lower urinary tract symptoms in benign prostatic hypertrophy with α-blockers.

Belayneh M, Korownyk C. Belayneh M, et al. Can Fam Physician. 2016 Sep;62(9):e523. Can Fam Physician. 2016. PMID: 27629686 Free PMC article. Review. No abstract available.

2

Terazosin, doxazosin, and prazosin: current clinical experience.

Akduman B, Crawford ED. Akduman B, et al. Urology. 2001 Dec;58(6 Suppl 1):49-54. doi: 10.1016/s0090-4295(01)01302-4. Urology. 2001. PMID: 11750252 Review.

3

A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.

Djavan B, Marberger M. Djavan B, et al. Eur Urol. 1999;36(1):1-13. doi: 10.1159/000019919. Eur Urol. 1999. PMID: 10364649

4

[Therapy of benign prostatic hyperplasia with alpha receptor blockers].

Stockamp K. Stockamp K. Urologe A. 1995 Jan;34(1):3-8. Urologe A. 1995. PMID: 7533449 Review. German.

5

The treatment of benign prostatic hyperplasia with alpha blockers in men over the age of 80 years.

Kaplan SA, Te AE, Ikeguchi E, Santarosa RP. Kaplan SA, et al. Br J Urol. 1997 Dec;80(6):875-9. doi: 10.1046/j.1464-410x.1997.00471.x. Br J Urol. 1997. PMID: 9439400

6

Terazosin for benign prostatic hyperplasia.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 1994 Feb 18;36(916):15-6. Med Lett Drugs Ther. 1994. PMID: 7508075 No abstract available.

7

Doxazosin-to-terazosin switch for benign prostatic hyperplasia.

Jansen DJ Jr, Resch ND, Hoffman RM. Jansen DJ Jr, et al. Am J Health Syst Pharm. 1999 Jul 1;56(13):1351. doi: 10.1093/ajhp/56.13.1351a. Am J Health Syst Pharm. 1999. PMID: 10683137 No abstract available.

8

The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Gonzalez CM, McVary KT. Gonzalez CM, et al. Curr Urol Rep. 2003 Aug;4(4):276-81. doi: 10.1007/s11934-003-0084-1. Curr Urol Rep. 2003. PMID: 12882718 Review. No abstract available.

9

Side effects of terazosin in the treatment of symptomatic benign prostatic hyperplasia.

McKiernan JM, Lowe FC. McKiernan JM, et al. South Med J. 1997 May;90(5):509-13. doi: 10.1097/00007611-199705000-00009. South Med J. 1997. PMID: 9160069 Review.

10

Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study.

Araki T, Monden K, Araki M. Araki T, et al. Acta Med Okayama. 2013;67(4):245-51. doi: 10.18926/AMO/51069. Acta Med Okayama. 2013. PMID: 23970323 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 27629686

108 results

Results by year